1PWV
Crystal structure of Anthrax Lethal Factor wild-type protein complexed with an optimised peptide substrate.
1PWV の概要
| エントリーDOI | 10.2210/pdb1pwv/pdb |
| 関連するPDBエントリー | 1PQW 1PWP 1PWU 1PWW |
| 分子名称 | Lethal factor, LF20 (2 entities in total) |
| 機能のキーワード | anthrax toxin, lethal factor, optimised peptide substrate, hydrolase |
| 由来する生物種 | Bacillus anthracis 詳細 |
| 細胞内の位置 | Secreted: P15917 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 185423.29 |
| 構造登録者 | Wong, T.Y.,Schwarzenbacher, R.,Liddington, R.C. (登録日: 2003-07-02, 公開日: 2004-02-03, 最終更新日: 2023-08-16) |
| 主引用文献 | Turk, B.E.,Wong, T.Y.,Schwarzenbacher, R.,Jarrell, E.T.,Leppla, S.H.,Collier, R.J.,Liddington, R.C.,Cantley, L.C. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat.Struct.Mol.Biol., 11:60-66, 2004 Cited by PubMed Abstract: Recent events have created an urgent need for new therapeutic strategies to treat anthrax. We have applied a mixture-based peptide library approach to rapidly determine the optimal peptide substrate for the anthrax lethal factor (LF), a metalloproteinase with an important role in the pathogenesis of the disease. Using this approach we have identified peptide analogs that inhibit the enzyme in vitro and that protect cultured macrophages from LF-mediated cytolysis. The crystal structures of LF bound to an optimized peptide substrate and to peptide-based inhibitors provide a rationale for the observed selectivity and may be exploited in the design of future generations of LF inhibitors. PubMed: 14718924DOI: 10.1038/nsmb708 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.85 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






